Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 132

Sort by

Sort Order Select

Journal Articles

Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity

Alejandra Ortiz-Ruiz, BSc, Yanira Ruiz-Heredia, Mehmet Samur, PhD, Pedro Aguilar-Garrido, Maria Luz Morales, Antonio Valeri, PhD, Almudena Garcia-Ortiz, PhD, Santiago Barrio, PhD, Carmen Bárcena, Rosa Maria Garcia-Martin, Vanesa Garrido, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD, María Teresa Cedena, Joaquin Martinez-Lopez, MD PhD, Maria Linares, PhD, Miguel Gallardo, PhD

Blood (2019) 134 (Supplement_1): 4408.

https://doi.org/10.1182/blood-2019-123950

Published: 2019

Journal Articles

Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma

Ya-Wei Qiang, MD PhD, Shiqiao Ye, PhD BSc, MSc, Yu Chen, Joshua Epstein, DSc, Faith E. Davies, MD, Gareth Morgan, MD PhD, Brian A Walker, PhD, Frits van Rhee, MD PhD

Blood (2019) 134 (Supplement_1): 4383.

https://doi.org/10.1182/blood-2019-130493

Published: 2019

Journal Articles

The Study of Proliferation Relative Long Non-Coding RNA in CD59- Cell from Paroxysmalnocturnal Hemoglobinuria Patients

Rong Fu, Jr., PhD, Honglei Wang, Hui Liu, Zonghong Shao, MD, Liyan Li

Blood (2019) 134 (Supplement_1): 5023.

https://doi.org/10.1182/blood-2019-128038

Published: 2019

Journal Articles

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Yi Xia, Jianxin Fu, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Li Wang, MD

Blood (2019) 134 (Supplement_1): 4284.

https://doi.org/10.1182/blood-2019-124609

Published: 2019

Journal Articles

Mesenchymal COX2-Derived PGD2 Activates an ILC2-Treg Axis to Promote Proliferation of Normal and Malignant HSPCs

Limei Wu, MD, PhD, Qiqi Lin, Zhilin Ma, Fabliha Chowdhury, Md Habibul Mazumder, Wei Du, MD PhD

Blood (2019) 134 (Supplement_1): 1208.

https://doi.org/10.1182/blood-2019-124144

Published: 2019

Journal Articles

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Xinyi Teng, BS, Hao Zhang, MD, Zuyu Liang, MD, Mi Shao, MD, Xiujian Wang, MD, Lijuan Ding, MD, Jiazhen Cui, msc, Yongxian Hu, MD, He Huang, MD PhD

Blood (2019) 134 (Supplement_1): 5609.

https://doi.org/10.1182/blood-2019-131680

Published: 2019

Journal Articles

Expression Profiling of mRNA By Next Generation Sequencing and the Development of Algorithm for Predicting Response in Acute Myeloid Leukemia

Maher Albitar, MD, Marina Y Konopleva, MD PhD, Hong Zhang, PhD, Ivan De Dios, BS, Wanlong Ma, Spiraggelos Antzoulatos, Steven M. Kornblau, MD, Antonio Cavazos, Sanam Loghavi, MD, Koichi Takahashi, MD, Hagop M. Kantarjian, MD, Courtney D. DiNardo, MDMSc

Blood (2019) 134 (Supplement_1): 1314.

https://doi.org/10.1182/blood-2019-127449

Published: 2019

Journal Articles

Blocking COX-2 for sickle cell pain relief

Katelyn E. Sadler, Cheryl L. Stucky

Blood (2019) 133 (18): 1924–1925.

https://doi.org/10.1182/blood-2019-03-900944

Published: 2019

Journal Articles

Sensitization of nociceptors by prostaglandin E 2 –glycerol contributes to hyperalgesia in mice with sickle cell disease

Iryna A. Khasabova, Megan Uhelski, Sergey G. Khasabov, Kalpna Gupta, Virginia S. Seybold, Donald A. Simone

Blood (2019) 133 (18): 1989–1998.

https://doi.org/10.1182/blood-2018-11-884346

Published: 2019

Journal Articles

Mutant KRAS and Brafs Upregulate Stress Granules and Mediate Drug Resistance, Which Can be Modulated By Cox2 Inhibition in Multiple Myeloma

Ya-Wei Qiang, MD PhD, Shiqiao Ye, PhD BSc, MSc, Yu Chen, Joshua Epstein, DSc, Brian A Walker, PhD, Frits van Rhee, MD PhD, Gareth Morgan, MD, Faith E. Davies, MD

Blood (2018) 132 (Supplement 1): 3166.

https://doi.org/10.1182/blood-2018-99-117459

Published: 2018

Journal Articles

FOS Expression Distinguishes Two Groups of Atypical CML (aCML) Allowing Targeted Therapy

Manja Meggendorfer, PhD, Wencke Walter, PhD, Stephan Hutter, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 3893.

https://doi.org/10.1182/blood-2018-99-111832

Published: 2018

Journal Articles

Knockout Tumor Microenvironment HO-1 Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Acute Myeloid Leukemia

Zhen Zhou, Qin Fang, Dan Ma, MD, Danna Wei, Xiuying Hu, Yudan Liao, Jishi Wang, PhD

Blood (2018) 132 (Supplement 1): 2782.

https://doi.org/10.1182/blood-2018-99-117808

Published: 2018

Journal Articles

Prostaglandin E 2 Glyceryl Ester Contributes to Hyperalgesia in a Humanized Model Pf Sickle Cell Disease through P2Y 6 Receptors

Donald Simone, PhD, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 1075.

https://doi.org/10.1182/blood-2018-99-118945

Published: 2018

Journal Articles

Transfusion of Storage-Damaged Red Blood Cells Induces Ferroptosis in Splenic Macrophages

Lyla Youssef, BA, Abdelhadi Rebbaa, PhD, Sergey Pampou, PhD, Brent R. Stockwell, PhD, Steven Spitalnik, MD

Blood (2017) 130 (Supplement 1): 3567.

https://doi.org/10.1182/blood.V130.Suppl_1.3567.3567

Published: 2017

Journal Articles

Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance

Richard J Burt, MBBS, Aditi Dey, PhD, Kenton Cheuk Yan Ng, BSc, Bingjie Liu, MSc, Teresa Marafioti, MD, Erik Sahai, PhD, Adele K Fielding, MBBS,PhDFRCP,FRCPath

Blood (2017) 130 (Supplement 1): 1165.

https://doi.org/10.1182/blood.V130.Suppl_1.1165.1165

Published: 2017

Journal Articles

Novel ARC//IL1β/PGE2/β-Catenin/ARC Circuit Regulates Leukemia and Leukemia Microenvironment and Drug Resistance in AML

Bing Z Carter, PhD, Po Yee Mak, Xiangmeng Wang, PhD, Hong Mu, MD PhD, Wenjing Tao, PhD, Vivian Ruvolo, PhD, Michael Andreeff, MD PhD

Blood (2017) 130 (Supplement 1): 3776.

https://doi.org/10.1182/blood.V130.Suppl_1.3776.3776

Published: 2017

Journal Articles

Activation Mediated By Peroxisome Proliferator-Activated Receptor (PPAR) Ligands and Brown Algae-Based Compounds: Different Mechanisms between Megakaryoblasts and Mature Platelets

Jin-Yeong Han, MD PhD, Jae-Lim Choi, Ri-Young Goh, Hyeon-Ho Lim, Joo-In Park

Blood (2017) 130 (Supplement 1): 4832.

https://doi.org/10.1182/blood.V130.Suppl_1.4832.4832

Published: 2017

Journal Articles

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

Paolo Catarsi, Francesca Cordero, Giulio Ferrero, Marco Beccuti, Valentina Poletto, Elisa Bonetti, PhD, Laura Villani, Margherita Massa, Gabriela Fois, Rita Campanelli, Umberto Magrini, Vittorio Rosti, Giovanni Barosi

Blood (2016) 128 (22): 4279.

https://doi.org/10.1182/blood.V128.22.4279.4279

Published: 2016

Journal Articles

Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively

Federica Costa, Marina Bolzoni, PhD, Rosanna Vescovini, PhD, Valentina Marchica, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Benedetta Dalla Palma, MD, Cristina Manferdini, Gina Lisignoli, Sabrina Manni, PhD, Francesco Piazza, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2016) 128 (22): 4464.

https://doi.org/10.1182/blood.V128.22.4464.4464

Published: 2016

Journal Articles

Ponatinib and Cardiovascular Complications

Alvin H. Schmaier, MD, Alona A. Merkulova, M.S., Steven Mitchell, Evi X Stavrou, MD

Blood (2016) 128 (22): 3055.

https://doi.org/10.1182/blood.V128.22.3055.3055

Published: 2016

NARROW

Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity

Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma

The Study of Proliferation Relative Long Non-Coding RNA in CD59- Cell from Paroxysmalnocturnal Hemoglobinuria Patients

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Mesenchymal COX2-Derived PGD2 Activates an ILC2-Treg Axis to Promote Proliferation of Normal and Malignant HSPCs

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Expression Profiling of mRNA By Next Generation Sequencing and the Development of Algorithm for Predicting Response in Acute Myeloid Leukemia

Blocking COX-2 for sickle cell pain relief

Sensitization of nociceptors by prostaglandin E 2 –glycerol contributes to hyperalgesia in mice with sickle cell disease

Mutant KRAS and Brafs Upregulate Stress Granules and Mediate Drug Resistance, Which Can be Modulated By Cox2 Inhibition in Multiple Myeloma

FOS Expression Distinguishes Two Groups of Atypical CML (aCML) Allowing Targeted Therapy

Knockout Tumor Microenvironment HO-1 Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Acute Myeloid Leukemia

Prostaglandin E 2 Glyceryl Ester Contributes to Hyperalgesia in a Humanized Model Pf Sickle Cell Disease through P2Y 6 Receptors

Transfusion of Storage-Damaged Red Blood Cells Induces Ferroptosis in Splenic Macrophages

Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance

Novel ARC//IL1β/PGE2/β-Catenin/ARC Circuit Regulates Leukemia and Leukemia Microenvironment and Drug Resistance in AML

Activation Mediated By Peroxisome Proliferator-Activated Receptor (PPAR) Ligands and Brown Algae-Based Compounds: Different Mechanisms between Megakaryoblasts and Mature Platelets

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively

Ponatinib and Cardiovascular Complications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only